0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Embryonic Stem Cell (hESC) Market Size, Status and Forecast 2019-2025
Published Date: March 2019
|
Report Code: QYRE-Othe-286
Home | Market Reports | Health | Reproductive Health
Global Human Embryonic Stem Cell hESC Market Size Status and Forecast 2019 to 2025

Global Human Embryonic Stem Cell (hESC) Market Size, Status and Forecast 2019-2025

Code: QYRE-Othe-286
Report
March 2019
104 Pages
QYResearch
Region: Global,
Description
Table of Content

Human embryonic stem cell research has emerged as an important
platform for the understanding and treatment of pediatric diseases.
From its inception, however, it has raised ethical concerns based
not on the use of stem cells themselves but on objections to the source
of the cells—specifically, the destruction of preimplantation human
embryos. Despite differences in public opinion on this issue, a large
majority of the public supports continued research using embryonic
stem cells.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
In 2018, the global Human Embryonic Stem Cell (hESC) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Human Embryonic Stem Cell (hESC) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Embryonic Stem Cell (hESC) development in United States, Europe and China.

The key players covered in this study
Astellas Institute of Regenerative Medicine (US)
Asterias Biotherapeutics, Inc. (US)
BD Biosciences (US)
Cell Cure Neurosciences Ltd. (Israel)
Cellular Dynamics International (US)
GE Healthcare (UK)
MilliporeSigma (US)
PerkinElmer, Inc. (US)
Reliance Life Sciences Ltd. (India)
Research & Diagnostics Systems, Inc. (US)
SABiosciences Corp. (US)
STEMCELL Technologies, Inc. (Canada)
Stemina Biomarker Discovery, Inc. (US)
Takara Bio, Inc. (Japan)
TATAA Biocenter AB (Sweden)
Thermo Fisher Scientific, Inc. (US)
UK Stem Cell Bank (UK)
ViaCyte, Inc. (US)
Vitrolife AB (Sweden)

Market segment by Type, the product can be split into
Totipotent Stem Cell
Pluripotent Stem Cell
Unipotent Stem Cell

Market segment by Application, split into
Research
Clinical Trials
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Embryonic Stem Cell (hESC) status, future forecast, growth opportunity, key market and key players.
To present the Human Embryonic Stem Cell (hESC) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Embryonic Stem Cell (hESC) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Embryonic Stem Cell (hESC) Market Size Growth Rate by Type (2014-2025)
1.4.2 Totipotent Stem Cell
1.4.3 Pluripotent Stem Cell
1.4.4 Unipotent Stem Cell
1.5 Market by Application
1.5.1 Global Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2025)
1.5.2 Research
1.5.3 Clinical Trials
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Human Embryonic Stem Cell (hESC) Market Size
2.2 Human Embryonic Stem Cell (hESC) Growth Trends by Regions
2.2.1 Human Embryonic Stem Cell (hESC) Market Size by Regions (2014-2025)
2.2.2 Human Embryonic Stem Cell (hESC) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Human Embryonic Stem Cell (hESC) Market Size by Manufacturers
3.1.1 Global Human Embryonic Stem Cell (hESC) Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Embryonic Stem Cell (hESC) Market Concentration Ratio (CR5 and HHI)
3.2 Human Embryonic Stem Cell (hESC) Key Players Head office and Area Served
3.3 Key Players Human Embryonic Stem Cell (hESC) Product/Solution/Service
3.4 Date of Enter into Human Embryonic Stem Cell (hESC) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019)
4.2 Global Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019)

5 United States
5.1 United States Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
5.2 Human Embryonic Stem Cell (hESC) Key Players in United States
5.3 United States Human Embryonic Stem Cell (hESC) Market Size by Type
5.4 United States Human Embryonic Stem Cell (hESC) Market Size by Application

6 Europe
6.1 Europe Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
6.2 Human Embryonic Stem Cell (hESC) Key Players in Europe
6.3 Europe Human Embryonic Stem Cell (hESC) Market Size by Type
6.4 Europe Human Embryonic Stem Cell (hESC) Market Size by Application

7 China
7.1 China Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
7.2 Human Embryonic Stem Cell (hESC) Key Players in China
7.3 China Human Embryonic Stem Cell (hESC) Market Size by Type
7.4 China Human Embryonic Stem Cell (hESC) Market Size by Application

8 Japan
8.1 Japan Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
8.2 Human Embryonic Stem Cell (hESC) Key Players in Japan
8.3 Japan Human Embryonic Stem Cell (hESC) Market Size by Type
8.4 Japan Human Embryonic Stem Cell (hESC) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
9.2 Human Embryonic Stem Cell (hESC) Key Players in Southeast Asia
9.3 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Type
9.4 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Application

10 India
10.1 India Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
10.2 Human Embryonic Stem Cell (hESC) Key Players in India
10.3 India Human Embryonic Stem Cell (hESC) Market Size by Type
10.4 India Human Embryonic Stem Cell (hESC) Market Size by Application

11 Central & South America
11.1 Central & South America Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
11.2 Human Embryonic Stem Cell (hESC) Key Players in Central & South America
11.3 Central & South America Human Embryonic Stem Cell (hESC) Market Size by Type
11.4 Central & South America Human Embryonic Stem Cell (hESC) Market Size by Application

12 International Players Profiles
12.1 Astellas Institute of Regenerative Medicine (US)
12.1.1 Astellas Institute of Regenerative Medicine (US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Embryonic Stem Cell (hESC) Introduction
12.1.4 Astellas Institute of Regenerative Medicine (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.1.5 Astellas Institute of Regenerative Medicine (US) Recent Development
12.2 Asterias Biotherapeutics, Inc. (US)
12.2.1 Asterias Biotherapeutics, Inc. (US) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Embryonic Stem Cell (hESC) Introduction
12.2.4 Asterias Biotherapeutics, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.2.5 Asterias Biotherapeutics, Inc. (US) Recent Development
12.3 BD Biosciences (US)
12.3.1 BD Biosciences (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Embryonic Stem Cell (hESC) Introduction
12.3.4 BD Biosciences (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.3.5 BD Biosciences (US) Recent Development
12.4 Cell Cure Neurosciences Ltd. (Israel)
12.4.1 Cell Cure Neurosciences Ltd. (Israel) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Embryonic Stem Cell (hESC) Introduction
12.4.4 Cell Cure Neurosciences Ltd. (Israel) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.4.5 Cell Cure Neurosciences Ltd. (Israel) Recent Development
12.5 Cellular Dynamics International (US)
12.5.1 Cellular Dynamics International (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Embryonic Stem Cell (hESC) Introduction
12.5.4 Cellular Dynamics International (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.5.5 Cellular Dynamics International (US) Recent Development
12.6 GE Healthcare (UK)
12.6.1 GE Healthcare (UK) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Embryonic Stem Cell (hESC) Introduction
12.6.4 GE Healthcare (UK) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.6.5 GE Healthcare (UK) Recent Development
12.7 MilliporeSigma (US)
12.7.1 MilliporeSigma (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human Embryonic Stem Cell (hESC) Introduction
12.7.4 MilliporeSigma (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.7.5 MilliporeSigma (US) Recent Development
12.8 PerkinElmer, Inc. (US)
12.8.1 PerkinElmer, Inc. (US) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Human Embryonic Stem Cell (hESC) Introduction
12.8.4 PerkinElmer, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.8.5 PerkinElmer, Inc. (US) Recent Development
12.9 Reliance Life Sciences Ltd. (India)
12.9.1 Reliance Life Sciences Ltd. (India) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Human Embryonic Stem Cell (hESC) Introduction
12.9.4 Reliance Life Sciences Ltd. (India) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.9.5 Reliance Life Sciences Ltd. (India) Recent Development
12.10 Research & Diagnostics Systems, Inc. (US)
12.10.1 Research & Diagnostics Systems, Inc. (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Human Embryonic Stem Cell (hESC) Introduction
12.10.4 Research & Diagnostics Systems, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.10.5 Research & Diagnostics Systems, Inc. (US) Recent Development
12.11 SABiosciences Corp. (US)
12.12 STEMCELL Technologies, Inc. (Canada)
12.13 Stemina Biomarker Discovery, Inc. (US)
12.14 Takara Bio, Inc. (Japan)
12.15 TATAA Biocenter AB (Sweden)
12.16 Thermo Fisher Scientific, Inc. (US)
12.17 UK Stem Cell Bank (UK)
12.18 ViaCyte, Inc. (US)
12.19 Vitrolife AB (Sweden)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Mifepristone Market Insights and Forecast to 2028
Global Mifepristone Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-19O7878
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Misoprostol Market Insights and Forecast to 2028
Global Misoprostol Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-24D7622
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Clomifene Market Insights and Forecast to 2028
Global Clomifene Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7761
Tue May 03 00:00:00 UTC 2022

Add to Cart